Dr Warwick Tong (pictured) will outline how the CTx CRC approaches research translation & commericalisation and the pathway that led to its recently announced multimillion dollar licensing deal.
Details
Date: Monday 22 February 2016
Time:
- 3.45pm - Registration opens
- 4.00pm - Seminar Begins
- 5.00pm - Networking and Drinks
Location: Melbourne Brain Centre, 30 Royal Parade, Parkville, VIC
Registration is free: www.biomedvic.org.au/symposium or at the event
Registration is free: www.biomedvic.org.au/symposium or at the event
More about Warwick Tong:
Dr Tong is CEO of Cancer Therapeutics CRC Pty Ltd. He brings more than 19 years experience of senior leadership in medical, clinical, commercial and business development in the major pharmaceutical and biotechnology sectors, including at GlaxoSmithKline (GSK) and MedInnovate.
Prior to his pharmaceutical industry career, Warwick worked in primary care medicine for 14 years, founding two medical clinics in New Zealand.
Prior to his pharmaceutical industry career, Warwick worked in primary care medicine for 14 years, founding two medical clinics in New Zealand.
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.